Stay updated on Pembrolizumab in Recurrent PCNSL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent PCNSL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent PCNSL Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new footer revision notice 'Revision: v3.3.3' appears, and the previous 'Revision: v3.3.2' text as well as the 'HHS Vulnerability Disclosure' link have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:16:50.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.2.0 was removed on the page. This is a maintenance update that does not affect study details or how users interact with the page.
    Difference
    0.1%
    Check dated 2025-11-25T11:29:26.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Top-of-page government funding/status notice has been removed. The study details, eligibility criteria, and contact information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:15:50.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    No significant content changes are evident; the updates appear to be minor UI/visual adjustments without altering the study details such as eligibility, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T20:53:28.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    4%
    Check dated 2025-10-06T07:58:45.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page shows a version upgrade from v3.0.2 to v3.1.0 and adds a new extension/contact code (+43140400 ext 44450).
    Difference
    0.1%
    Check dated 2025-09-29T04:35:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent PCNSL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent PCNSL Clinical Trial page.